273 related articles for article (PubMed ID: 30509601)
21. Use of transient elastography to assess hepatic steatosis and fibrosis in patients with juvenile idiopathic arthritis during methotrexate treatment.
Niyasom C; Soponkanaporn S; Vilaiyuk S; Lertudomphonwanit C; Getsuwan S; Tanpawpong P; Kaewduang P; Sobhonslidsuk A
Clin Rheumatol; 2024 Jan; 43(1):423-433. PubMed ID: 38062311
[TBL] [Abstract][Full Text] [Related]
22. Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter.
Wong VW; Petta S; Hiriart JB; Cammà C; Wong GL; Marra F; Vergniol J; Chan AW; Tuttolomondo A; Merrouche W; Chan HL; Le Bail B; Arena U; Craxì A; de Lédinghen V
J Hepatol; 2017 Sep; 67(3):577-584. PubMed ID: 28506907
[TBL] [Abstract][Full Text] [Related]
23. Longitudinal Transient Elastography Measurements Used in Follow-up for Patients with Cystic Fibrosis.
Van Biervliet S; Verdievel H; Vande Velde S; De Bruyne R; De Looze D; Verhelst X; Geerts A; Robberecht E; Van Vlierberghe H
Ultrasound Med Biol; 2016 Apr; 42(4):848-54. PubMed ID: 26806442
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and characteristics of cystic fibrosis liver disease: a study highlighting the lack of histological diagnosis.
Issa Z; Gohy S; Zech F; Baldin P; Delire B; Dahlqvist G
Clin Res Hepatol Gastroenterol; 2022 Nov; 46(9):101977. PubMed ID: 35772685
[TBL] [Abstract][Full Text] [Related]
25. Estimating steatosis and fibrosis: Comparison of acoustic structure quantification with established techniques.
Karlas T; Berger J; Garnov N; Lindner F; Busse H; Linder N; Schaudinn A; Relke B; Chakaroun R; Tröltzsch M; Wiegand J; Keim V
World J Gastroenterol; 2015 Apr; 21(16):4894-902. PubMed ID: 25945002
[TBL] [Abstract][Full Text] [Related]
26. Screening for hepatic fibrosis and steatosis in Turkish patients with type 2 diabetes mellitus: A transient elastography study.
Demir M; Deyneli O; Yılmaz Y
Turk J Gastroenterol; 2019 Mar; 30(3):266-270. PubMed ID: 30411703
[TBL] [Abstract][Full Text] [Related]
27. Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease.
Leung DH; Khan M; Minard CG; Guffey D; Ramm LE; Clouston AD; Miller G; Lewindon PJ; Shepherd RW; Ramm GA
Hepatology; 2015 Nov; 62(5):1576-83. PubMed ID: 26223427
[TBL] [Abstract][Full Text] [Related]
28. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
Imajo K; Kessoku T; Honda Y; Tomeno W; Ogawa Y; Mawatari H; Fujita K; Yoneda M; Taguri M; Hyogo H; Sumida Y; Ono M; Eguchi Y; Inoue T; Yamanaka T; Wada K; Saito S; Nakajima A
Gastroenterology; 2016 Mar; 150(3):626-637.e7. PubMed ID: 26677985
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with significant liver steatosis and fibrosis as assessed by transient elastography in patients with one or more components of the metabolic syndrome.
Mikolasevic I; Milic S; Orlic L; Stimac D; Franjic N; Targher G
J Diabetes Complications; 2016; 30(7):1347-53. PubMed ID: 27324703
[TBL] [Abstract][Full Text] [Related]
30. Genetic modifiers of liver disease in cystic fibrosis.
Bartlett JR; Friedman KJ; Ling SC; Pace RG; Bell SC; Bourke B; Castaldo G; Castellani C; Cipolli M; Colombo C; Colombo JL; Debray D; Fernandez A; Lacaille F; Macek M; Rowland M; Salvatore F; Taylor CJ; Wainwright C; Wilschanski M; Zemková D; Hannah WB; Phillips MJ; Corey M; Zielenski J; Dorfman R; Wang Y; Zou F; Silverman LM; Drumm ML; Wright FA; Lange EM; Durie PR; Knowles MR;
JAMA; 2009 Sep; 302(10):1076-83. PubMed ID: 19738092
[TBL] [Abstract][Full Text] [Related]
31. How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound.
Carvalhana S; Leitão J; Alves AC; Bourbon M; Cortez-Pinto H
Liver Int; 2014 Jul; 34(6):e111-7. PubMed ID: 24034415
[TBL] [Abstract][Full Text] [Related]
32. Comparison of Controlled Attenuation Parameter and Liver Biopsy to Assess Hepatic Steatosis in Pediatric Patients.
Desai NK; Harney S; Raza R; Al-Ibraheemi A; Shillingford N; Mitchell PD; Jonas MM
J Pediatr; 2016 Jun; 173():160-164.e1. PubMed ID: 27039224
[TBL] [Abstract][Full Text] [Related]
33. Potential impact of screening for fatty liver disease by transient elastography with liver stiffness and controlled attenuation parameter measurements: a pilot study.
Peiseler M; Creutzfeldt A; Cassens I; Glaubke C; Kroll C; Lohse AW; Weiler-Normann C
Z Gastroenterol; 2017 Aug; 55(8):754-760. PubMed ID: 28655068
[No Abstract] [Full Text] [Related]
34. Relationship of liver stiffness and controlled attenuation parameter measured by transient elastography with diabetes mellitus in patients with chronic liver disease.
Ahn JM; Paik YH; Kim SH; Lee JH; Cho JY; Sohn W; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
J Korean Med Sci; 2014 Aug; 29(8):1113-9. PubMed ID: 25120322
[TBL] [Abstract][Full Text] [Related]
35. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
[TBL] [Abstract][Full Text] [Related]
36. Metabolic syndrome, hepatic fibrosis, and steatosis diagnosed by liver stiffness measurement and controlled attenuation parameter after liver transplantation: the impact on long-term survival.
Eshraghian A; Fattahi MR; Taghavi A; Shamsaeefar A; Mansoorian M; Kazemi K; Nikeghbalian S; Malek-Hosseini SA
Expert Rev Gastroenterol Hepatol; 2022 Oct; 16(10):1003-1009. PubMed ID: 36254767
[TBL] [Abstract][Full Text] [Related]
37. Value of controlled attenuation parameter in fibrosis prediction in nonalcoholic steatohepatitis.
Lee JI; Lee HW; Lee KS
World J Gastroenterol; 2019 Sep; 25(33):4959-4969. PubMed ID: 31543686
[TBL] [Abstract][Full Text] [Related]
38. Clinical and genetic risk factors for cystic fibrosis-related liver disease in Egyptian CF children: A single-center experience.
El-Faramawy A; Nasr SZ; Emam MMSA; Fahmy HMH
Pediatr Pulmonol; 2024 Feb; 59(2):465-471. PubMed ID: 38038166
[TBL] [Abstract][Full Text] [Related]
39. The inverse effect of meal intake on controlled attenuation parameter and liver stiffness as assessed by transient elastography.
Ratchatasettakul K; Rattanasiri S; Promson K; Sringam P; Sobhonslidsuk A
BMC Gastroenterol; 2017 Apr; 17(1):50. PubMed ID: 28407734
[TBL] [Abstract][Full Text] [Related]
40. Assessment of Liver Disease Progression in Cystic Fibrosis Using Transient Elastography.
Gominon AL; Frison E; Hiriart JB; Vergniol J; Clouzeau H; Enaud R; Bui S; Fayon M; de Ledinghen V; Lamireau T
J Pediatr Gastroenterol Nutr; 2018 Mar; 66(3):455-460. PubMed ID: 29112089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
